TickerFactsScreenerDevelopers

ALNYLAM PHARMACEUTICALS, INC. (ALNY) — Operating Income

Annual figures by fiscal year, from SEC filings.

2008: -$27.84M2009: -$48.11M2010: -$44.07M2011: -$54.82M2012: -$129.46M2013: -$92.94M2014: -$404.98M2015: -$296.01M2016: -$424.59M2017: -$500.09M2018: -$814.67M2019: -$939.43M2020: -$828.44M2021: -$708.65M2022: -$785.07M2023: -$282.18M2024: -$176.88M2025: $501.58M$501.58M
2008Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$501.58M+383.6%
2024-$176.88M+37.3%
2023-$282.18M+64.1%
2022-$785.07M-10.8%
2021-$708.65M+14.5%
2020-$828.44M+11.8%
2019-$939.43M-15.3%
2018-$814.67M-62.9%
2017-$500.09M-17.8%
2016-$424.59M-43.4%
2015-$296.01M+26.9%
2014-$404.98M-335.7%
2013-$92.94M+28.2%
2012-$129.46M-136.2%
2011-$54.82M-24.4%
2010-$44.07M+8.4%
2009-$48.11M-72.8%
2008-$27.84M—